Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    11120692 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases
Conditions: Coronary Artery Diseases;   Myocardial Infarction;   Stable Angina
Interventions: Biological: influenza vaccine;   Biological: placebo for influenza vaccine
2 Recruiting Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)
Conditions: Heart Failure;   Influenza
Interventions: Other: Sterile saline;   Drug: inactivated trivalent influenza vaccine
3 Active, not recruiting Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
Condition: Heart Failure
Interventions: Drug: inactivated trivalent influenza vaccine;   Other: Sterile saline

Study has passed its completion date and status has not been verified in more than two years.